Capital Fund Management S.A. Xencor Inc Transaction History

Capital Fund Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$27.76 - $33.42 $240,734 - $289,818	-8,672 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$20.69 - $37.79 $137,133 - $250,472	-6,628 Reduced 43.32%	8,672 $259,000
Q4 2019 Feb 13, 2020	BUY	$32.75 - $41.43 $29,475 - $37,287	900 Added 6.25%	15,300 $526,000
Q3 2019 Nov 13, 2019	BUY	$33.73 - $46.27 $485,711 - $666,288	14,400 New	14,400 $486,000

216

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.48B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.